Vesugen – Research-Grade Vascular Bioregulator Tripeptide

Vesugen is a synthetic short-chain peptide bioregulator (Lys-Glu-Asp) developed within the Khavinson family of tissue-specific peptides associated with vascular and blood-vessel systems. As a low-molecular-weight tripeptide, Vesugen is structurally distinct from larger signaling peptides and lipid-modified analogs, and in laboratory research settings it is utilized as a reference material for studying short-peptide–chromatin interaction models, tissue-specific gene expression regulation, and structure–activity relationships within the vascular peptide class.

Owing to its defined sequence and compact structure, Vesugen exhibits physicochemical properties that allow researchers to examine peptide stability, nuclear localization behavior, and putative regulatory activity in vitro without reliance on larger native proteins. Its reproducible synthetic profile supports controlled use in mechanistic assays, comparative bioregulator studies, and exploratory biochemical research conducted under controlled laboratory conditions. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.

Related research compounds

Cortagen · Pinealon · Cartalax · Epitalon · Thymalin

Documentation and methods

Analytical testing · How to read a COA · Batch COAs · Storage and handling · What are research peptides

Important Information About This Research Product

1. 1 Your vials are not empty. The lyophilized material may collect at the bottom of the vial and can appear minimal prior to inspection.
2. 2 All products are supplied as lyophilized (freeze-dried) powder and require reconstitution. Bacteriostatic water is not supplied.
3. 3 Store in a dry, cool, and dark environment away from UV exposure. For optimal preservation, storage at approximately 4°C is recommended.
4. 4 This material is strictly for laboratory and research use only. No instructions regarding reconstitution, dosing, or administration can be provided.